Free Trial

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Shares Bought by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Bioceres Crop Solutions logo with Consumer Staples background

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 135.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 752,335 shares of the company's stock after acquiring an additional 432,206 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 1.20% of Bioceres Crop Solutions worth $4,574,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of America Corp DE grew its stake in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after buying an additional 3,735 shares in the last quarter. Jump Financial LLC acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at about $72,000. Northern Trust Corp acquired a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at about $93,000. Ping Capital Management Inc. grew its stake in shares of Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after buying an additional 3,000 shares in the last quarter. Finally, Stifel Financial Corp grew its stake in shares of Bioceres Crop Solutions by 51.9% in the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock valued at $377,000 after buying an additional 21,168 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX opened at $4.65 on Monday. Bioceres Crop Solutions Corp. has a fifty-two week low of $3.51 and a fifty-two week high of $11.86. The business has a 50 day moving average price of $4.35 and a two-hundred day moving average price of $5.53. The company has a quick ratio of 0.96, a current ratio of 1.33 and a debt-to-equity ratio of 0.43. The firm has a market cap of $291.61 million, a PE ratio of 232.62 and a beta of 0.40.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Lake Street Capital lowered their target price on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a research note on Friday, February 7th. Canaccord Genuity Group lowered their target price on Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Oppenheimer lowered their target price on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Bioceres Crop Solutions has an average rating of "Buy" and a consensus price target of $8.63.

View Our Latest Stock Analysis on Bioceres Crop Solutions

Bioceres Crop Solutions Company Profile

(Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Featured Articles

Institutional Ownership by Quarter for Bioceres Crop Solutions (NASDAQ:BIOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bioceres Crop Solutions Right Now?

Before you consider Bioceres Crop Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.

While Bioceres Crop Solutions currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines